2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01551940 (ClinicalTrials.gov)	February 2012	9/3/2012	Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea	Evaluation of Efficacy of Botulinum Toxin Type A in the Treatment of Sialorrhea in the Patient Affec ...	Sialorrhea;Amyotrophic Lateral Sclerosis	Drug: Botox injection;Drug: Placebo injection	Hospices Civils de Lyon	NULL	Completed	18 Years	N/A	Both	18	Phase 2	France
2	EUCTR2010-023161-21-FR (EUCTR)	23/11/2011	06/09/2011	Sclérose Latérale Amyotrophique (SLA) – toxine botulinique A (Botox®)	Evaluation de la toxine botulinique dans le traitement du trouble salivaire chez le patient atteint ...	Sclérose Latérale Amyotrophique (SLA) MedDRA version: 14.0;Level: PT;Classification code 10002026;Te ...	Trade Name: BOTOX 100 UNITES ALLERGAN (PR1) Other descriptive name: BOTULINUM TOXIN TYPE A	Hospices Civils de Lyon	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	France

First Previous1Next Last